2023-09-01 2024-08-31 false Capium Accounts Production 1.1 12799421 2023-09-01 2024-08-31 12799421 bus:AbridgedAccounts 2023-09-01 2024-08-31 12799421 bus:Micro-entities 2023-09-01 2024-08-31 12799421 bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 12799421 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 12799421 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 12799421 2023-09-01 2024-08-31 12799421 2024-08-31 12799421 bus:RegisteredOffice 2023-09-01 2024-08-31 12799421 core:WithinOneYear 2024-08-31 12799421 core:AfterOneYear 2024-08-31 12799421 1 2023-09-01 2024-08-31 12799421 bus:Director1 2023-09-01 2024-08-31 12799421 bus:Director1 2024-08-31 12799421 bus:Director1 2022-09-01 2023-08-31 12799421 2022-09-01 12799421 bus:LeadAgentIfApplicable 2023-09-01 2024-08-31 12799421 2022-09-01 2023-08-31 12799421 2023-08-31 12799421 core:WithinOneYear 2023-08-31 12799421 core:AfterOneYear 2023-08-31 12799421 bus:EntityAccountantsOrAuditors 2022-09-01 2023-08-31 12799421 core:MotorCars 2023-09-01 2024-08-31 12799421 core:MotorCars 2024-08-31 12799421 core:MotorCars 2023-08-31 12799421 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-08-31 12799421 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-08-31 12799421 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 12799421 core:CostValuation core:Non-currentFinancialInstruments 2023-08-31 12799421 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-08-31 12799421 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 12799421 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 12799421 core:Non-currentFinancialInstruments 2024-08-31 12799421 core:Non-currentFinancialInstruments 2023-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12799421
England and Wales
Abridged Accounts
for the year ended 31 August 2024
for
O-PHARM LIMITED

O-PHARM LIMITED Contents Page For the year ended 31 August 2024
Statement of financial position | 1

Registered Number: 12799421 O-PHARM LIMITED Statement of Financial Position As at 31 August 2024
|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 30,000 |  |  | 0
Current assets |  | 398,192 |  |  | 193,981 |
Creditors: amount falling due within one year |  | (126,422) |  |  | (67,258) |
Net current assets |  |  | 271,770 |  |  | 126,723
Total assets less current liabilities |  |  | 301,770 |  |  | 126,723
Net assets |  |  | 301,770 |  |  | 126,723
Capital and reserves |  |  | 301,770 |  |  | 126,723
NOTES TO THE ACCOUNTS General Information O-PHARM LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12799421, registration address 102 Clare Road, Maidenhead, SL6 4DQ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2. | Average number of employees Average number of employees during the year was 2 (2023 : 1).
For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the director on 19 May 2025 and were signed by:
-------------------------------- Mohammad Omar Rafiq Director
1